In the matter of Parabolic Drugs Limited Ca No. 389-2019 in Cp (Ib) No. 102-Chd-CHD-2018
Case brief
What is this about?
The NCLT approved the resolution plan for Parabolic Drugs Limited submitted by Akums Drugs & Pharmaceuticals Ltd. The Tribunal examined compliance with Section 30(2) and 31 of the IBC, including payments to dissenting creditors and operational stakeholders, and satisfied itself that the plan was viable and effective.
What did the court decide?
Order approving the resolution plan submitted by Akums Drugs & Pharmaceuticals Ltd., cease of moratorium, and directions to forward CIRP records to the Board.